James A. Burke

5.1k total citations · 1 hit paper
78 papers, 2.7k citations indexed

About

James A. Burke is a scholar working on Ophthalmology, Molecular Biology and Physiology. According to data from OpenAlex, James A. Burke has authored 78 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Ophthalmology, 21 papers in Molecular Biology and 18 papers in Physiology. Recurrent topics in James A. Burke's work include Glaucoma and retinal disorders (27 papers), Retinal Diseases and Treatments (15 papers) and Retinal Development and Disorders (11 papers). James A. Burke is often cited by papers focused on Glaucoma and retinal disorders (27 papers), Retinal Diseases and Treatments (15 papers) and Retinal Development and Disorders (11 papers). James A. Burke collaborates with scholars based in United States, Ireland and Australia. James A. Burke's co-authors include David E. Potter, Roberto Levi, Navin K. Kapur, Morton J. Kern, Srihari S. Naidu, Thomas Tu, James A. Goldstein, V. Vivian Dimas, Michael M. Givertz and Wilson Y. Szeto and has published in prestigious journals such as Journal of Neuroscience, Journal of the American College of Cardiology and Circulation Research.

In The Last Decade

James A. Burke

78 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care

2015 466 citations Charanjit S. Rihal, Srihari S. Naidu et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James A. Burke United States	28	999	866	626	603	495	78	2.7k
Akiko Higuchi Japan	24	354 0.4×	396 0.5×	27 0.0×	688 1.1×	323 0.7×	73	3.5k
James J. Jang United States	13	380 0.4×	32 0.0×	163 0.3×	543 0.9×	436 0.9×	29	1.8k
H G Eichler Austria	26	202 0.2×	149 0.2×	43 0.1×	304 0.5×	111 0.2×	49	1.8k
James V. Winkler United States	15	277 0.3×	29 0.0×	85 0.1×	353 0.6×	260 0.5×	25	1.8k
Stanley A. Rubin United States	25	368 0.4×	45 0.1×	75 0.1×	946 1.6×	117 0.2×	60	2.0k
Phillip S. Mushlin United States	17	469 0.5×	34 0.0×	68 0.1×	928 1.5×	58 0.1×	37	1.9k
M K Jasani United Kingdom	20	455 0.5×	49 0.1×	168 0.3×	90 0.1×	225 0.5×	65	2.5k
Douglas F. Larson United States	29	415 0.4×	15 0.0×	163 0.3×	913 1.5×	152 0.3×	90	2.5k
M. Hartog United Kingdom	27	458 0.5×	41 0.0×	290 0.5×	199 0.3×	88 0.2×	114	2.6k

Countries citing papers authored by James A. Burke

Since Specialization

Citations

This map shows the geographic impact of James A. Burke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Burke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Burke more than expected).

Fields of papers citing papers by James A. Burke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Burke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Burke. The network helps show where James A. Burke may publish in the future.

Co-authorship network of co-authors of James A. Burke

This figure shows the co-authorship network connecting the top 25 collaborators of James A. Burke. A scholar is included among the top collaborators of James A. Burke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Burke. James A. Burke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Robinson, Michael R., et al.. (2018). Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target Tissues. Journal of Ocular Pharmacology and Therapeutics. 35(1). 50–57. 59 indexed citations

Ridder, William H., et al.. (2017). Effect of Povidone Iodine 5% on the Cornea, Vision, and Subjective Comfort. Optometry and Vision Science. 94(7). 732–741. 34 indexed citations

Rihal, Charanjit S., Srihari S. Naidu, Michael M. Givertz, et al.. (2015). 2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care. Journal of the American College of Cardiology. 65(19). e7–e26. 466 indexed citations breakdown →

Ghosn, Corine, Yong Li, Werhner Orilla, et al.. (2011). Treatment of Experimental Anterior and Intermediate Uveitis by a Dexamethasone Intravitreal Implant. Investigative Ophthalmology & Visual Science. 52(6). 2917–2917. 36 indexed citations

Burke, James A., T. Lin, Werhner Orilla, et al.. (2006). Extended Effect of a Dexamethasone Posterior Segment Drug Delivery System (DexDDS) on VEGF–Induced Retinopathy. Investigative Ophthalmology & Visual Science. 47(13). 4491–4491. 1 indexed citations

Gupta, Anuj, James A. Burke, & Alfred A. Bové. (2006). Coronary arterial revascularization: Past, present, future: Part I—historical trials. Clinical Cardiology. 29(7). 290–294. 1 indexed citations

Spada, Clayton S., et al.. (2005). Posurdex Inhibits Retinal Vasculopathy and Neuropathy by Intravitreal Vascular Endothelial Growth Factor (VEGF) in Monkeys. Investigative Ophthalmology & Visual Science. 46(13). 3951–3951. 3 indexed citations

Burke, James A., et al.. (2005). Oral Memantine Increases Rate of ERG Recovery in Rabbits Following an Acute Retinal Ischemic Insult Induced by Elevated IOP. Investigative Ophthalmology & Visual Science. 46(13). 4660–4660. 1 indexed citations

Orilla, Werhner, et al.. (2004). Diurnal telemetry IOP in rabbits and monkeys: Effect of timolol. Investigative Ophthalmology & Visual Science. 45(13). 2078–2078. 1 indexed citations

10.

Liang, Yuanbo, et al.. (2002). Upregulation of Regulator of G Protein Signaling 5 (RGS5) in the Iris-Ciliary Body of Chronic Ocular Hypertensive Primates. Investigative Ophthalmology & Visual Science. 43(13). 3387–3387. 1 indexed citations

11.

Spada, Clayton S., A L Nieves, James A. Burke, Larry A. Wheeler, & David F. Woodward. (2001). Differential Effects of α -Adrenoceptor Agonists on Human Retinal Microvessel Diameter. Journal of Ocular Pharmacology and Therapeutics. 17(3). 255–277. 7 indexed citations

12.

Woodward, David F., et al.. (1996). In-vivo Activity and Enzymatic Hydrolysis of Novel Prostaglandin F2αProdrugs in Ocular Tissues. Experimental Eye Research. 63(4). 411–423. 7 indexed citations

13.

Levine, Marc J., et al.. (1990). Clinical and angiographic results of balloon-expandable intracoronary stents in right coronary artery stenoses. Journal of the American College of Cardiology. 16(2). 332–339. 85 indexed citations

14.

Potter, David E., et al.. (1990). Ocular inhibitory effects of the dopamine DA₂ agonist (Ha‐118) in cats and rabbits. Journal of Autonomic Pharmacology. 10(3). 153–162. 4 indexed citations

15.

Potter, David E. & James A. Burke. (1988). LY141865: A Relatively Selective DA ₂ Agonist with Complex Ocular Activity. Journal of Ocular Pharmacology and Therapeutics. 4(1). 19–28. 5 indexed citations

16.

Burke, James A. & David E. Potter. (1986). The Ocular Effects of Xylazine in Rabbits, Cats, and Monkeys. Journal of Ocular Pharmacology and Therapeutics. 2(1). 9–21. 36 indexed citations

17.

Potter, David E. & James A. Burke. (1985). Does B-HT 920 Lower Intraocular Pressure in Cats by Interacting with α ₂ - and/or DA ₂ Adrenoceptors?. Journal of Ocular Pharmacology and Therapeutics. 1(1). 29–45. 12 indexed citations

18.

Burke, James A., et al.. (1985). Mechanism of the Ocular Hypotensive Action of Ketanserin. Journal of Ocular Pharmacology and Therapeutics. 1(2). 137–147. 29 indexed citations

19.

Potter, David E. & James A. Burke. (1984). An in vivo model for dissociating α ₂ - and DA ₂ -adrenoceptor activity in an ocular adnexa: Utility of the cat nictitating membrane preparation. Current Eye Research. 3(11). 1289–1298. 19 indexed citations

20.

Burke, James A., et al.. (1982). Cardiac effects of acetyl glyceryl ether phosphorylcholine. Federation Proceedings. 41(3). 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact